Neeraj Agarwal, MD
Enriched profileProfessor of Medicine and Presidential Endowed Chair of Cancer Research; Director, Genitourinary Oncology Program; Director, Center of Investigational Therapeutics; Senior Director of Clinical Research · Huntsman Cancer Institute
Neeraj Agarwal is Professor of Medicine and Presidential Endowed Chair of Cancer Research; Director, Genitourinary Oncology Program; Director, Center of Investigational Therapeutics; Senior Director of Clinical Research at Huntsman Cancer Institute. OpenAlex indexes 1,047 publications with 22,618 citations (h-index 66); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Neeraj Agarwal is Professor of Medicine and Presidential Endowed Chair of Cancer Research at Huntsman Cancer Institute, University of Utah, Salt Lake City, UT (Department of Internal Medicine, Division of Medical Oncology). The public record shows 1,047 publications with 22,618 citations (h-index 66), centered on Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 4 registered clinical trials, 2 NIH-funded awards (2023–2026).
- Most recent indexed publication: 2026 · JCO precision oncology
- Top research focus: Prostate Cancer Treatment and Research
- 4 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 99 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 261.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)
Sponsor: University of Utah
Industry payments
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202515 payments
- Janssen Global Services, LLCProgram year202512 payments
- Telix PharmaceuticalsProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
48.7%Cytochrome P450 17A1 Inhibitor31.4%Abiraterone Acetate100%Part D≥36 patientsAndrogen Receptor Inhibitor9.6%Xtandi69%Bicalutamide31%Part D≥14 patientsMetabolism & gastrointestinal
37.6%Corticosteroid31.6%Prednisone100%Part D≥51 patientsSerotonin-3 Receptor Antagonist3.7%Ondansetron Hcl100%Part D≥19 patientsHormonal (systemic)
4.8%l-Thyroxine4.8%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Clinical Protocol and Data Management
Utah State Higher Education System--University of Utah
FY2026$269,454P30CA042014 - Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial
Utah State Higher Education System--University of Utah
FY2025$692,911R01CA281759 - Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression: A double-blind randomized controlled trial
University of Utah
FY2024$651,255R01CA281759
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.
Journal of clinical oncology
Article2026 - Molecular Characterization of KLK2 RNA Expression in Prostate Cancer.
Clinical cancer research
Article2026
Most-cited works
by citation count (OpenAlex)- 01Olaparib for Metastatic Castration-Resistant Prostate Cancer2,246 citations2020
- 02Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study1,802 citations2020
- 03Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer1,516 citations2019
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/neeraj-agarwal-md-fasco-126a068b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
neerajagarwal.me
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neerajagarwal.me ↗ - Doximity
doximity.com/pub/neeraj-agarwal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
ascodaily.libsyn.com/asco21-advancing-treatment-for-genitourinary-cancers-with-dr-neeraj-agarwal-0
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascodaily.libsyn.com ↗ - Other
dailynews.ascopubs.org/do/practice-informing-research-across-gu-oncology-highlights-gu25
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dailynews.ascopubs.org ↗ - Other
backtable.com/shows/urology/contributors/dr-neeraj-agarwal
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →backtable.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
All India Institute of Medical Sciences (AIIMS), New Delhi, India
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grandroundsinurology.com ↗ - Internal Medicine Residency
University of Iowa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grandroundsinurology.com ↗ - Geriatric Medicine Fellowship
University of Iowa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grandroundsinurology.com ↗ - Hematology/Oncology Fellowship
Huntsman Cancer Institute, University of Utah
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grandroundsinurology.com ↗
Editorial & leadership roles
journal and society appointments- Director
Genitourinary Oncology (GU) Program, Huntsman Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗ - Director
Center of Investigational Therapeutics (CIT), Huntsman Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗ - Senior Director of Clinical Research (overseeing clinical and late translational research)
Huntsman Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →grandroundsinurology.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- ASCO Daily News podcast guest
"#ASCO21: Advancing Treatment For Genitourinary Cancers With Dr. Neeraj Agarwal"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascodaily.libsyn.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Josef Prchal, MD
Huntsman Cancer Institute
Ahmad Halwani, MD
Huntsman Cancer Institute
Vedran Radojcic, MD
Huntsman Cancer Institute
Talicia Savage, MD, PhD
Huntsman Cancer Institute